Article
The GNB3 C825T polymorphism affects response to HCV therapy with pegylated interferon in HCV/HIV co-infected but not in HCV mono-infected patients.
Journal of hepatology - 1 Sept 2007
Ahlenstiel Golo, Nischalke Hans Dieter, Bueren Karin, Berg Thomas, Vogel Martin, Biermer Michael, Grünhage Frank, Sauerbruch Tilman, Rockstroh Jürgen, Spengler Ulrich, Nattermann Jacob
Abstract excerpt
BACKGROUND/AIMS: Response to HCV treatment with pegylated interferon-alpha is variable but might at least in part depend on genetic host factors. The G protein beta3 unit (GNB3) C825T polymorphism has been shown to affect treatment response in HCV mono-infection. Here, we analyzed the impact of the GNB3 genotype in the context of HCV/HIV co-infection. METHODS: HIV/HCV co-infected (n=112) and HCV mono-infected...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
